{{Rsnum
|rsid=4956145
|Gene=HADH
|Chromosome=4
|position=108009883
|Orientation=plus
|ReferenceAllele=T
|MissenseAllele=C
|GMAF=0.1074
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=HADH
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 81.4 | 18.6 | 0.0
| HCB | 89.1 | 10.9 | 0.0
| JPT | 95.6 | 4.4 | 0.0
| YRI | 38.8 | 45.6 | 15.6
| ASW | 54.4 | 38.6 | 7.0
| CHB | 89.1 | 10.9 | 0.0
| CHD | 97.2 | 2.8 | 0.0
| GIH | 87.1 | 11.9 | 1.0
| LWK | 58.2 | 39.1 | 2.7
| MEX | 96.6 | 3.4 | 0.0
| MKK | 66.7 | 31.4 | 1.9
| TSI | 86.3 | 12.7 | 1.0
| HapMapRevision=28
}}{{Venter SNP
|rsid=4956145
|allele=C
|frequency=0.958
|uid=1103654509365
|type=homozygous_SNP
|hugo=HADH
|ensembl gene=ENSG00000138796
|ensembl transcript=ENST00000309522
|sift=TOLERATED
|disease=Defects in HADHSC are the cause of 3-alpha-hydroxyacyl- CoA dehydrogenase deficiency (HAD deficiency) (MIM:609609). HAD deficiency is a metabolic disorder with various clinical presentations including hypoglycemia, hepatoencephalopathy, myopathy or cardiomyopathy, and in some cases sudden death.
}}

{{GET Evidence
|gene=HADH
|aa_change=Leu86Pro
|aa_change_short=L86P
|impact=not reviewed
|qualified_impact=Insufficiently evaluated not reviewed
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs4956145
|overall_frequency_n=9113
|overall_frequency_d=10758
|overall_frequency=0.847091
|n_genomes=56
|n_genomes_annotated=0
|n_haplomes=91
|n_articles=0
|n_articles_annotated=0
|qualityscore_in_silico=3
|qualitycomment_in_silico=Y
|gene_in_genetests=Y
|genetests_testable=Y
|genetests_reviewed=Y
|nblosum100=7
|autoscore=2
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}